Nuo Therapeutics (CMXI) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Nuo Therapeutics, Inc.  (CMXI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Nuo Therapeutics Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CMXI Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 66.14 % 43.99 % 66.93 % 39.87 %
Gross Margin (Q2 TTM) 66.14 % 46.77 % 58.11 % 39.06 %
Gross Profit Margin 5 Yr. Avg. - 38.3 % 62.72 % 37 %
EBITDA Margin (Q2 MRQ) -3.71 % 18.78 % 22.25 % 15.48 %
EBITDA Margin (Q2 TTM) -17.63 % 16.89 % 19.98 % 15.66 %
EBITDA Margin 5 Yr. Avg. - 20.99 % 24.7 % 18.67 %
Operating Margin (Q2 MRQ) -9.42 % 13.32 % 23.96 % 13.3 %
Operating Margin (Q2 TTM) -28.4 % 9.04 % 17.62 % 13.14 %
Operating Margin 5 Yr. Avg. - 13.35 % 19.97 % 12.69 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 11.23 % 15.92 % 11.36 %
Pre-Tax Profit Margin (Q2 TTM) -13.91 % 9.3 % 12.73 % 11.06 %
Pre-Tax Profit Margin 5 Yr. Avg. - 11.71 % 16.33 % 9.89 %
Net Margin (Q2 MRQ) -15.69 % 7.75 % 11.42 % 7.96 %
Net Margin (Q2 TTM) -29.6 % 4.38 % 10.37 % 7.81 %
Net Margin 5 Yr. Avg. - 6.03 % 13.52 % 7.26 %